Dr. Elijah Stommel | Toxicology | Best Researcher Award
Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda ๐, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth ๐ง , renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care ๐ก; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology ๐ฅ, academia ๐, and public health advocacy ๐งฌ.
Profile
Education ๐
Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine ๐; he earned a B.A. with High Honors in Music from Bowdoin College ๐ต (1977), pursued advanced coursework at MIT ๐๏ธ, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole ๐ฌ โ blending physiology, neurology, and music to form a truly interdisciplinary academic foundation ๐.
Experience ๐จโ๐ซ
With over three decades in clinical neurology ๐ง , Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013โpresent) ๐จโ๐ซ; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 ๐ฅ, held multiple consultant roles across Vermont and New Hampshire ๐บ๏ธ, and co-directs the Electromyography Lab โก, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments ๐.
Awards & Recognitions ๐
Dr. Stommelโs commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award ๐ (2011); he is a Fellow of the American Academy of Neurology ๐๏ธ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology ๐ง , complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education ๐๐ก.
Research Interests ๐ฌ
Dr. Stommelโs research revolves around neurodegenerative diseases, especially ALS ๐งฌ, exploring environmental toxins ๐ฟ, nanotechnology ๐งช, and biomarkers ๐ to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology ๐ง , he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues ๐๐ก.